Hinge Health (HNGE) Long-Term Investments (2025 - 2026)

Hinge Health (HNGE) reported Long-Term Investments of $89.8 million for Q1 2026, down 20.68% sequentially from $113.2 million in Q4 2025.

Hinge Health (HNGE) Long-Term Investments (2025 - 2026) Analysis & Trends

Hinge Health (HNGE) has 2 years of Long-Term Investments data on file, last reported at $89.8 million in Q1 2026.

For the quarter ending Q1 2026, Long-Term Investments changed N/A year-over-year to $89.8 million; the trailing twelve-month figure through Mar 2026 stood at $89.8 million (changed N/A YoY), and the FY2025 full-year result was $113.2 million, changed N/A from the prior year.
Long-Term Investments retreated to $89.8 million in Q1 2026, from $113.2 million in the prior quarter.
In the past five years, Long-Term Investments ranged from a high of $113.2 million in Q4 2025 to a low of $15.1 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Veeva Systems	31.52 Bn	24.21 Bn	662.02 Mn	-
2	BrightSpring Health Services	14.78 Bn	13.88 Bn	482.22 Mn	7.49 Mn
3	Healthequity	8.11 Bn	7.84 Bn	256.31 Mn	-
4	10x Genomics	6.03 Bn	5.49 Bn	106.18 Mn	-
5	Hinge Health	5.96 Bn	5.64 Bn	154.23 Mn	89.77 Mn
6	Waystar Holding	4.43 Bn	4.36 Bn	216.84 Mn	-
7	MiniMed	4.40 Bn	4.10 Bn	480.00 Mn	-
8	Doximity	3.92 Bn	3.17 Bn	125.97 Mn	-
9	Privia Health	3.19 Bn	2.77 Bn	-	-
10	Omnicell	1.89 Bn	1.66 Bn	140.36 Mn	58.21 Mn

Download Data